크리스퍼 테라퓨틱스 (CRSP)

Apr 02, 2025

CRISPR Therapeutics (CRSP) Rebounds After Six Session Downtrend - GuruFocus

Apr 02, 2025

Apr 02, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 12-Month LowWhat's Next? - MarketBeat

Apr 02, 2025

Apr 01, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 8.7%Here's Why - MarketBeat

Apr 01, 2025

Apr 01, 2025

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

NEOS Investment Management LLC Decreases Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 01, 2025

Apr 01, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Loomis Sayles & Co. L P - MarketBeat

Apr 01, 2025

Mar 31, 2025

CRSP stock touches 52-week low at $35.52 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

CRSP stock touches 52-week low at $35.52 amid market challenges - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today - MSN

Mar 31, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

Intellia Focuses on Pipeline Development Amid Stiff Competition - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance

Mar 31, 2025

Mar 31, 2025

Blair William & Co. IL Decreases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 31, 2025

Mar 31, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Buys 22,647 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 31, 2025

Mar 30, 2025

82,095 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by Raymond James Financial Inc. - MarketBeat

Mar 30, 2025

Mar 30, 2025

How to Take Advantage of moves in (CRSP) - Stock Traders Daily

Mar 30, 2025

Mar 30, 2025

Avantax Advisory Services Inc. Invests $269,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 30, 2025

Mar 29, 2025

HighTower Advisors LLC Has $1.25 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Magnetar Financial LLC Acquires New Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 27, 2025

Mar 26, 2025

CRISPR Therapeutics COO to step down in April By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO to Step Down - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO Julianne Bruno Resigns - TipRanks

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics COO to step down in April - Investing.com

Mar 26, 2025

Mar 26, 2025

CRISPR Therapeutics Announces Transition of Chief Operating Officer - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance

Mar 26, 2025

Mar 26, 2025

Crispr therapeutics’ general counsel sells shares worth $131,317 By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 25, 2025

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025

Mar 25, 2025

CRISPR Therapeutics Set To Reach Previous Heights (NASDAQ:CRSP) - Seeking Alpha

Mar 25, 2025

Mar 25, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Mar 25, 2025

Mar 25, 2025

Buy Rating for Crispr Therapeutics AG Driven by Promising Clinical Data and Diversified Pipeline - TipRanks

Mar 25, 2025

Mar 24, 2025

12 Most Promising Biotech Stocks According to Wall Street Analysts - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CFO Prasad Raju sells $90,582 in shares By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CEO sells shares worth $413,578 By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics COO Bruno Julianne sells $70,668 in stock By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics’ general counsel sells shares worth $131,317 - Investing.com India

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CFO Prasad Raju sells $90,582 in shares - Investing.com India

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics COO Bruno Julianne sells $70,668 in stock - Investing.com

Mar 24, 2025

Mar 24, 2025

Crispr therapeutics CEO sells shares worth $413,578 - Investing.com

Mar 24, 2025

Mar 24, 2025

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN

Mar 24, 2025

Mar 24, 2025

Koss Olinger Consulting LLC Has $1.35 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 24, 2025

Mar 23, 2025

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing - MSN

Mar 23, 2025

Mar 22, 2025

2 Beaten-Down Stocks to Buy on the Dip - Yahoo Finance

Mar 22, 2025

Mar 21, 2025

Nikko Asset Management Americas Inc. Has $108.07 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 21, 2025

Mar 21, 2025

Contrarius Group Holdings Ltd Takes $14.52 Million Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 21, 2025